84 related articles for article (PubMed ID: 8712478)
21. Total red cell Ca2+ content and rheological determinants in a group of subjects with vascular atherosclerotic disease.
Caimi G; Lo Presti R; Serra A; Grifò G; Romano A; Catania A; Sarno A
Microcirc Endothelium Lymphatics; 1990 Feb; 6(1):35-43. PubMed ID: 2355903
[TBL] [Abstract][Full Text] [Related]
22. Rheological leukocyte indexes in diabetes mellitus type II.
Perego MA; Danese C; Volpe MS; Zavattaro E; Calisi L
Ann Cardiol Angeiol (Paris); 1992 Dec; 41(10):A75-80. PubMed ID: 1300912
[TBL] [Abstract][Full Text] [Related]
23. Platelet membrane fluidity in non-insulin-dependent diabetes mellitus (NIDDM) subjects, in subjects with vascular atherosclerotic disease (VAD) and in VAD subjects with NIDDM.
Caimi G; Canino B; Montana M; Catania A; Lo Presti R
Thromb Haemost; 1999 Jul; 82(1):149. PubMed ID: 10456470
[No Abstract] [Full Text] [Related]
24. Polymorphonuclear leukocyte membrane fluidity, at baseline and after in vitro activation, in obesity with or without diabetes mellitus.
Lo Presti R; Sinagra D; Montana M; Scarpitta AM; Catania A; Caimi G
Acta Diabetol; 2002 Apr; 39(1):29-33. PubMed ID: 12043936
[TBL] [Abstract][Full Text] [Related]
25. Plasma membrane fluidity and polarity of polymorphonuclear leukocytes from children with type I diabetes mellitus.
Kantar A; Littarru GP; Falcioni G; Cherubini V; Coppa GV; Fiorini R
J Diabetes Complications; 1999; 13(5-6):243-50. PubMed ID: 10764997
[TBL] [Abstract][Full Text] [Related]
26. Erythrocyte aggregation and erythrocyte membrane properties in type 2 diabetes mellitus and in vascular atherosclerotic disease.
Caimi G; Canino B; Romano A; Catania A; Lo Presti R
Thromb Haemost; 2000 Mar; 83(3):516-7. PubMed ID: 10744168
[No Abstract] [Full Text] [Related]
27. Acute ischemic stroke : polymorphonuclear leukocyte membrane fluidity and cytosolic Ca(2+) concentration at baseline and after chemotactic activation.
Caimi G; Ferrara F; Montana M; Meli F; Canino B; Carollo C; Presti RL
Stroke; 2000 Jul; 31(7):1578-82. PubMed ID: 10884457
[TBL] [Abstract][Full Text] [Related]
28. Polymorphonuclear leukocyte membrane fluidity before and after activation in subjects with insulin resistance.
Caimi G; Sinagra D; Canino B; Scarpitta AM; Montana M; Bonaventura V; Lo Presti R
Acta Diabetol; 2000 Mar; 37(1):9-12. PubMed ID: 10928230
[TBL] [Abstract][Full Text] [Related]
29. Polymorphonuclear integrins, membrane fluidity, and cytosolic Ca(2+) content after activation in essential hypertension.
Caimi G; Presti RL; Carollo C; Musso M; Porretto F; Canino B; Catania A; Cerasola G
Hypertension; 2000 Nov; 36(5):813-7. PubMed ID: 11082148
[TBL] [Abstract][Full Text] [Related]
30. [Plasma, erythrocyte and platelet magnesium in essential hyperTension, diabetes mellitus without and with macrovascular complications and atherosclerotic vascular disease].
Grifò G; Lo Presti R; Montana M; Canino B; Caimi G
Recenti Prog Med; 1995 Nov; 86(11):431-6. PubMed ID: 8539474
[TBL] [Abstract][Full Text] [Related]
31. Membrane fluidity of polymorphonuclear leukocytes from children with primary ciliary dyskinesia.
Kantar A; Oggiano N; Giorgi PL; Fiorini R
Pediatr Res; 1993 Dec; 34(6):725-8. PubMed ID: 8108183
[TBL] [Abstract][Full Text] [Related]
32. Leukocyte flow properties, polymorphonuclear membrane fluidity and cytosolic Ca2+ content in chronic renal failure.
Caimi G; Canino B; Vaccaro F; Montana M; Ventimiglia G; Grifo G; Lo Presti R
Nephron; 1996; 73(4):714. PubMed ID: 8856280
[No Abstract] [Full Text] [Related]
33. Exercise test: leukocyte rheology and polymorphonuclear cystolic Ca2+ content in normals and in subjects submitted to coronary angioplasty.
Caimi G; Assennato P; Canino B; Montana M; Ventimiglia G; Lo Presti R
Clin Hemorheol Microcirc; 1997; 17(6):421-7. PubMed ID: 9502526
[No Abstract] [Full Text] [Related]
34. Polymorphonuclear leukocytes in non-insulin-dependent diabetes mellitus: abnormalities in metabolism and function.
Alexiewicz JM; Kumar D; Smogorzewski M; Klin M; Massry SG
Ann Intern Med; 1995 Dec; 123(12):919-24. PubMed ID: 7486486
[TBL] [Abstract][Full Text] [Related]
35. Polymorphonuclear leukocyte integrin profile in vascular atherosclerotic disease.
Lo Presti R; Canino B; Montana M; Ferrara F; Carollo C; Porretto F; Caimi G
Clin Hemorheol Microcirc; 2004; 30(1):53-60. PubMed ID: 14967884
[TBL] [Abstract][Full Text] [Related]
36. Alterations in membrane fluidity of diabetic polymorphonuclear leukocytes.
Kantar A; Giorgi PL; Curatola G; Fiorini R
Biochem Med Metab Biol; 1991 Dec; 46(3):422-6. PubMed ID: 1793618
[TBL] [Abstract][Full Text] [Related]
37. Reduced number of circulating monocytes after institution of insulin therapy--relevance for development of atherosclerosis in diabetics?
Persson SU; Larsson H; Odeberg H
Angiology; 1998 Jun; 49(6):423-33. PubMed ID: 9631887
[TBL] [Abstract][Full Text] [Related]
38. Mastoparan, a wasp venom peptide, identifies two discrete mechanisms for elevating cytosolic calcium and inositol trisphosphates in human polymorphonuclear leukocytes.
Perianin A; Snyderman R
J Immunol; 1989 Sep; 143(5):1669-73. PubMed ID: 2760463
[TBL] [Abstract][Full Text] [Related]
39. Erythrocyte, platelet and polymorphonuclear leukocyte membrane dynamic properties in essential hypertension.
Caimi G
Clin Hemorheol Microcirc; 1997; 17(3):199-208. PubMed ID: 9356784
[TBL] [Abstract][Full Text] [Related]
40. Total red cell calcium content, cytosolic red cell free calcium and erythrocyte membrane dynamic properties in diabetes mellitus.
Caimi G; Serra A; Lo Presti R; Grifo G; Romano A; Galluzzo A; Sarno A
Microcirc Endothelium Lymphatics; 1991; 7(4-6):257-66. PubMed ID: 1815107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
